February 10, 2026 03:31 pm (IST)
Follow us:
Mumbai, Mar 14 (IBNS) Pharmaceutical major Pfizer has stopped manufacture and sale of popular cough syrup Corex with immediate effect after a ban by the Government.
“This is to inform you that the Government of India has prohibited the manufacture for sale, sale and distribution of fixed dose combination of Chlopheniramine Maleate + Codeine Syrup with immediate effect,” Pfizer said in a BSE filing on Monday.
“In view of this, the company has discontinued the manufacture and sale of its drug Corex with immediate effect," it said.
Pfizer said it believed Corex had a "well-established efficacy and safety profile in India for more than 30 years," adding that the company was "exploring all possible options at its disposal."
Pfizer said the prohibition on Corex is likely to have an adverse impact on the revenue and profitability of the company.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Happy Chocolate Day: Your favourite treat comes with surprising health benefits, reveals study
Mon, Feb 09 2026
Grey matter decline, anxiety, sleep issues: What Menopause really does to your brain, study gives you the answer
Sun, Feb 08 2026
Men at risk by 35? Major study reveals early heart disease warning
Wed, Feb 04 2026
Your bedtime could be putting your heart in danger, scientists warn
Mon, Feb 02 2026